Inhibition of P-Glycoprotein Mediated Drug Transport : A Unifying Mechanism to Explain the Interaction Between Digoxin and Quinidine

Circulation - United States
doi 10.1161/01.cir.99.4.552
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Clinically Significant Interaction Between Digoxin and Quinidine.

BMJ
1979English

Lipid-Mediated Inhibition Mechanism of P-Glycoprotein

Biophysical Journal
Biophysics
2019English

A Novel Electron Paramagnetic Resonance Approach to Determine the Mechanism of Drug Transport by P-Glycoprotein

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

Association Between the Number of Coadministered P-Glycoprotein Inhibitors and Serum Digoxin Levels in Patients on Therapeutic Drug Monitoring

BMC Medicine
Medicine
2004English

Reconstitution of Drug Transport by Purified P-Glycoprotein

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Selective Modulation of P-Glycoprotein-Mediated Drug Resistance

British Journal of Cancer
Cancer ResearchOncology
2001English

Multiple Drug Transport Pathways Through Human P-Glycoprotein

Biochemistry
Biochemistry
2015English

Novel Drug Development Utilizing Transport Function of P-Glycoprotein.

Drug Metabolism and Pharmacokinetics
1998English

Overcoming P-Glycoprotein Mediated Drug Resistance With Noscapine Derivatives

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy